A fantastic panel discussion moderated by Matthew Herper of STAT explored how science and capital intersect to drive innovation in biotech with Karen Heidelberger (Deerfield Management), John Mendlein (Flagship Pioneering), Viq Pervaaz (NYCEDC), Carlo Rizzuto (Versant Ventures).